APA

Rasmussen L. J. H., Knudsen A., Katzenstein T. L., Gerstoft J., Obel N., Jørgensen N. R., Kronborg G., Benfield T., Kjaer A., Eugen-Olsen J. & Lebech A. (20161227). Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. : HIV medicine.

Chicago

Rasmussen L J H, Knudsen A, Katzenstein T L, Gerstoft J, Obel N, Jørgensen N R, Kronborg G, Benfield T, Kjaer A, Eugen-Olsen J and Lebech A-M. 20161227. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. : HIV medicine.

Harvard

Rasmussen L. J. H., Knudsen A., Katzenstein T. L., Gerstoft J., Obel N., Jørgensen N. R., Kronborg G., Benfield T., Kjaer A., Eugen-Olsen J. and Lebech A. (20161227). Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. : HIV medicine.

MLA

Rasmussen L J H, Knudsen A, Katzenstein T L, Gerstoft J, Obel N, Jørgensen N R, Kronborg G, Benfield T, Kjaer A, Eugen-Olsen J and Lebech A-M. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. : HIV medicine. 20161227.